Across TCGA cell cohorts, OR6C68 mutation is significantly associated with the drug of many other genes, with 5 significant associations in total. SKIN shows the largest number of these associations.

The most reproducible OR6C68-associated genes across cancer lineages are CAY10566, Ribociclib, and BAY-HDAC11_2. Each is linked with OR6C68 in more than 1 cancer types. Because this analysis shows association rather than direction, both OR6C68-to-partner and partner-to-OR6C68 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (OR6C68→partner) and Y-score (partner→OR6C68) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
SKIN	CAY10566 →	+0.375	+2.641	.048	.049	3	1
SKIN	Ribociclib →	+0.431	+2.658	.001	.043	2	1
SKIN	BAY-HDAC11_2 →	+0.393	+2.807	.006	.048	1	1
SKIN	PFI3 →	+0.298	+2.748	.002	.042	1	1
SKIN	GW-2580 →	+0.185	+2.859	.019	.024	1	1

Each partner links to its Q-omics profile. Showing the 5 strongest of 5 associations by consensus.

Exploration

OR6C68 survival (RNA) · tumor vs normal (RNA) · all OR6C68 data types